Works matching IS 14642662 AND DT 2010 AND VI 11 AND IP 5

Results: 8

Development and initial validation of a brief screener for focused HIV prevention efforts.
Published in:
HIV Medicine, 2010, v. 11, n. 5, p. 318, doi. 10.1111/j.1468-1293.2009.00774.x
By:
- Bennett, M.;
- Strachan, E.;
- Uldall, K.
Publication type:
Article
Hospitalization risk following initiation of highly active antiretroviral therapy.
Published in:
HIV Medicine, 2010, v. 11, n. 5, p. 289, doi. 10.1111/j.1468-1293.2009.00776.x
By:
- Berry, S. A.;
- Manabe, Y. C.;
- Moore, R. D.;
- Gebo, K. A.
Publication type:
Article
Non-medically supervised treatment interruptions among participants in a universally accessible antiretroviral therapy programme.
Published in:
HIV Medicine, 2010, v. 11, n. 5, p. 299, doi. 10.1111/j.1468-1293.2009.00779.x
By:
- Moore, D. M.;
- Zhang, W.;
- Yip, B.;
- Genebat, M.;
- Lima, V. D.;
- Montaner, J. S. G.;
- Hogg, R. S.
Publication type:
Article
Prevalence and factors associated with renal impairment in HIV-infected patients, ANRS C03 Aquitaine Cohort, France.
Published in:
HIV Medicine, 2010, v. 11, n. 5, p. 308, doi. 10.1111/j.1468-1293.2009.00780.x
By:
- Déti, E. K.;
- Thiébaut, R.;
- Bonnet, F.;
- Lawson-Ayayi, S.;
- Dupon, M.;
- Neau, D.;
- Pellegrin, J. L.;
- Malvy, D.;
- Tchamgoué, S.;
- Dabis, F.;
- Morlat, P.
Publication type:
Article
Persistence of CCR5 usage among primary human immunodeficiency virus isolates of individuals receiving intermittent interleukin-2.
Published in:
HIV Medicine, 2010, v. 11, n. 5, p. 349, doi. 10.1111/j.1468-1293.2009.00782.x
By:
- Ghezzi, S.;
- Pacciarini, F.;
- Nozza, S.;
- Racca, S.;
- Mariani, S. A.;
- Vicenzi, E.;
- Lazzarin, A.;
- Veglia, F.;
- Tambussi, G.;
- Poli, G.
Publication type:
Article
Mid-dosing interval concentration of atazanavir and virological outcome in patients treated for HIV-1 infection.
Published in:
HIV Medicine, 2010, v. 11, n. 5, p. 326, doi. 10.1111/j.1468-1293.2009.00785.x
By:
- Fabbiani, M.;
- Di Giambenedetto, S.;
- Ragazzoni, E.;
- Colafigli, M.;
- Prosperi, M.;
- Cauda, R.;
- Navarra, P.;
- De Luca, A.
Publication type:
Article
Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48-week randomized comparison with abacavir/zidovudine/lamivudine in HIV-infected Ugandan adults with low CD4 cell counts.
Published in:
HIV Medicine, 2010, v. 11, n. 5, p. 334, doi. 10.1111/j.1468-1293.2009.00786.x
By:
- Munderi, P.;
- Walker, A. S.;
- Kityo, C.;
- Babiker, A. G.;
- Ssali, F.;
- Reid, A.;
- Darbyshire, J. H.;
- Grosskurth, H.;
- Mugyenyi, P.;
- Gibb, D. M.;
- Gilks, C. F.
Publication type:
Article
Introduction of pharmacogenetic screening for the human leucocyte antigen (HLA) B*5701 variant in Polish HIV-infected patients.
Published in:
HIV Medicine, 2010, v. 11, n. 5, p. 345, doi. 10.1111/j.1468-1293.2009.00787.x
By:
- Parczewski, M.;
- Leszczyszyn-Pynka, M.;
- Wnuk, A.;
- Urbañska, A.;
- Fuksiñska, K.;
- Bander, D.;
- Boroñ-Kaczmarska, A.
Publication type:
Article